All In Biotech

Drug Trial Radar · NCT07200908

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 172 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

172

Planned (sponsor's estimate)

Start

Aug 27, 2025

Primary completion

Jun 30, 2027

Study completion Sep 30, 2029

Sponsor

Lead sponsor
Mirum Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Oct 1, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, global, randomized, open-label, multicenter, trial evaluating brelovitug (BJT-778) vs bulevirtide for the treatment of chronic hepatitis delta infection (CHD). The main goal of this study is to test the effectiveness of brelovitug compared to bulevirtide as a long-term treatment in patients with chronic HDV infection.

Conditions

  • Chronic Hepatitis D Infection

Interventions

  • Brelovitug 300 mgDrug

    Route of administration- Subcutaneous Injection

  • Bulevirtide 2 mg and Brelovitug - 300 mgDrug

    Route of Administration- Subcutaneous Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants with a composite endpoint of virologic response and ALT normalizationTime frame: Week 48

Locations

57 sites in 12 countries. Site status is shown where the registry gives one.

  • Medical University of Graz

    Graz, Austria · Recruiting

  • Universitätsklinikum St. Pölten

    Sankt Pölten, Austria · Recruiting

  • Fakultni Nemocnice Brno

    Brno, Brno, Czechia · Recruiting

  • Fakultni Nemocnice Hradec Kralove

    Hradec Králové, Hradec Králové, Czechia · Recruiting

  • Krajská nemocnice Liberec, a.s.

    Liberec, Liberec, Czechia · Recruiting

  • Institute For Clinical And Experimental Medicine

    Prague, Prague, Czechia · Recruiting

  • Klin Med s.r.o.

    Prague, Prague, Czechia · Recruiting

  • Hôpital Estaing

    Clermont-Ferrand, France · Recruiting

  • Hôpital Beaujon

    Clichy, France · Recruiting

  • University Hospital Henri Mondor - APHP

    Créteil, France · Recruiting

  • CHU Grenoble Alpes Hopital Nord Michallon

    La Tronche, France · Recruiting

  • Centre Hospitalier de Versailles _ Hopital Andre Magnot

    Le Chesnay, France · Recruiting

  • Lille Regional University Hospital Centre

    Lille, France · Recruiting

  • University Hospital Limoges

    Limoges, France · Recruiting

  • Hôpital de la Croix-Rousse

    Lyon, France · Recruiting

  • Hôpital Pitié Salpêtrière

    Paris, France · Recruiting

  • Hopital Cochin

    Paris, France · Recruiting

  • CHU de Bordeaux - Hopital Haut-Leveque

    Pessac, France · Recruiting

  • Centre Hospitalier Universitaire De Rennes

    Rennes, France · Recruiting

  • Hôpital Rangueil

    Toulouse, France · Recruiting

  • Universitätsklinikum Düsseldorf

    Düsseldorf, Germany · Recruiting

  • Medizinische Hochschule Hannover

    Hanover, Germany · Recruiting

  • Goethe University Frankfurt

    Frankfurt, Frankfurt, Germany · Recruiting

  • Rostock University Medical Center

    Rostock, Rostock, Germany · Recruiting

  • ASST Papa Giovanni XXIII

    Bergamo, Italy · Recruiting

  • Humanitas Research Hospital

    Milan, Italy · Recruiting

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

    Milan, Italy · Recruiting

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy · Recruiting

  • University of Parma

    Parma, Italy · Recruiting

  • AOU Pisana - Cisanello

    Pisa, Italy · Recruiting

  • National Institute of Infectious Diseases Lazzaro Spallanzani

    Roma, Italy · Recruiting

  • Aga Khan University, Aga Khan Hospital and Medical College Foundation

    Karachi, Pakistan · Recruiting

  • National Institute of Infectious Diseases Prof Dr Matei Bals

    Bucharest, Romania · Recruiting

  • Fundeni Clinical Institute

    Bucharest, Romania · Recruiting

  • Spitalul Clinic de Boli Infectioase Constanta

    Constanța, Romania · Recruiting

  • National Institute Of Infectious Diseases

    Bucharest, Bucharest, Romania · Recruiting

  • Spitalul Clinic De Boli Infectioase Si Tropicale Dr. Victor Babes

    Bucharest, Bucharest, Romania · Recruiting

  • Centrul Medical Unirea S.R.L

    Iași, Lasi, Romania · Recruiting

  • Hospital Clinic Provincial De Barcelona

    Barcelona, Spain · Recruiting

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain · Recruiting

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.